Author: Mouallem Meir Antipov Natalia Mayan Haim Sela Ben Farfel Zvi
Publisher: Springer Publishing Company
ISSN: 0920-3206
Source: Cardiovascular Drugs and Therapy, Vol.21, Iss.1, 2007-02, pp. : 63-67
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Atrial Fibrillation due to Late Amiodarone-Induced Thyrotoxicosis
Clinical Drug Investigation, Vol. 28, Iss. 8, 2008-01 ,pp. :
The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology
Current Radiopharmaceuticals, Vol. 10, Iss. 3, 2017-11 ,pp. :
Continuation of Amiodarone Therapy Despite Type II Amiodarone-Induced Thyrotoxicosis
By Uzan Laurent
Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. :